October 2025 Small Animal Seminar: Oncology

Join us in-person or virtually, for the first seminar of the 2025-2026 Small Animal Series 
on Weds. Oct 8, 2025!

Registration Pricing:

MVMA Member DVM: $210
MVMA Member LVT/Practice Staff: $180

Non-member DVM: $260
Non-member LVT/Practice Staff: $210

• Registration for in-person participation will close at 5pm on Oct. 1, 2025
• Registration for virtual participation will close at 7am on Wednesday, Oct. 8, 2025
• Small Animal Seminars WILL  NOT be recorded for on-demand viewing

ABOUT THE SPEAKER: 

Philip J. Bergman DVM, MS, PhD, Diplomate ACVIM (Oncology)
Adjunct Associate Faculty Member, Memorial Sloan-Kettering Cancer Center (MSKCC)

Dr. Bergman is the is the principal veterinary investigator for the fully licensed canine melanoma vaccine (Oncept). Dr. Bergman is an adjunct faculty member of the Memorial Sloan-Kettering Cancer Center.  Dr. Bergman most recently was the Global Director of Clinical Studies for Mars Veterinary Health and VCA (2024 and 2011-2023, respectively). He served as the Chief Medical Officer for BrightHeart Veterinary Centers from 2007 to 2011; from 1999 – June 2007 he was the head of the Donaldson-Atwood Cancer Center at AMC.  After finishing veterinary school from Colorado State in 1990, he was an intern at Kansas State (90-91) and returned to CSU for his medical oncology residency (91-94) and then completed a PhD Fellowship in human cancer biology from the M.D. Anderson Cancer Center in Houston (94-99).  He was previously Chair of the ACVIM Board of Regents and President of the Veterinary Cancer Society.